Pathology Consultation for the Gynecologic Oncologist: What the Surgeon Wants to Know.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30133316.
- Also identified by DOI 10.5858/arpa.2018-0122-RA.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical management of gynecologic malignancies is often multimodal. Pathologic diagnoses, patient-related factors, and disease-related factors all contribute to clinical decision making. To review the role of surgical pathology in treatment planning among women with gynecologic malignancies. An analysis of relevant literature (PubMed Plus [National Center for Biotechnology Information, Bethesda, Maryland] and Medline [Ovid, New York, New York]) and the authors' clinical practice experience were used. Pathologic evaluation of gynecologic malignancies with traditional histopathology, assessment of genetic alterations, and identification of tumor biomarkers are critical to traditional treatment planning as well as for ongoing clinical trials.
Medical subject headings
- Biomarkers, Tumor
- Genital Neoplasms, Female